Physician profile
Laura Schiff
NPI 1558904177
$22,141.41
in general payments reported to CMS, 2019-2025
62 companies · $4,668 in 2025
The $4,668 reported for 2025 was more than what 99% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $4,589 · 2022: $4,034 · 2023: $5,024 · 2024: $3,827 · 2025: $4,668.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $14K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13,518.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $5,998.72 | 2021-2025 | |
| Novo Nordisk INC | $2,042.86 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $1,488.61 | 2021-2025 | Evenity, Repatha, Otezla |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,432.37 | 2021-2025 | Xifaxan |
| Pfizer INC. | $1,420.29 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,032.31 | 2021-2025 | Fasenra, Farxiga, Airsupra |
| Lilly USA, LLC | $783.55 | 2021-2025 | Jardiance, Mounjaro, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $706.45 | 2021-2025 | Jardiance, Ofev, Jascayd |
| Corcept Therapeutics | $584.55 | 2021-2025 | Korlym |
| Glaxosmithkline, LLC. | $541.67 | 2021-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Daiichi Sankyo INC. | $506.74 | 2021-2025 | Injectafer |
| Merck Sharp & Dohme LLC | $420.51 | 2021-2025 | Gardasil 9, Vaxneuvance, Pneumovax 23 |
| Biohaven Pharmaceutical Holding Company LTD. | $358.40 | 2022 | |
| Madrigal Pharmaceuticals | $353.10 | 2025 | Rezdiffra |
| Janssen Pharmaceuticals, INC | $303.19 | 2021-2024 | Xarelto |
Show all 62 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $297.89 | 2021-2025 | |
| Esperion Therapeutics, INC. | $287.55 | 2021-2025 | Nexletol |
| Exact Sciences Corporation | $260.84 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Biohaven Pharmaceuticals, INC. | $195.73 | 2021 | |
| Biosense Webster, INC. | $190.58 | 2021-2023 | Carto 3 |
| Eisai INC. | $190.44 | 2021-2025 | |
| Amarin Pharma, INC. | $182.29 | 2021-2022 | |
| Edwards Lifesciences Corporation | $180.74 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Dexcom, INC. | $164.53 | 2021-2025 | Dexcom G6 Transmitter |
| Vanda Pharmaceuticals INC. | $162.65 | 2025 | Fanapt |
| Astellas Pharma US INC | $149.79 | 2021-2025 | Veozah |
| Indivior INC. | $133.13 | 2024-2025 | Sublocade |
| Takeda Pharmaceuticals U.S.A., INC. | $121.48 | 2021-2024 | Trintellix |
| Phathom Pharmaceuticals, INC. | $117.93 | 2024-2025 | Voquezna |
| Biotronik INC. | $115.96 | 2025 | Amvia Edge |
| Vertex Pharmaceuticals Incorporated | $112.32 | 2025 | |
| Genzyme Corporation | $103.56 | 2024 | |
| Sanofi Pasteur INC. | $90.90 | 2023-2025 | |
| Sumitomo Pharma America, INC. | $88.60 | 2024-2025 | Gemtesa |
| Braeburn INC. | $86.60 | 2025 | Brixadi |
| Novartis Pharmaceuticals Corporation | $72.33 | 2024 | |
| Otsuka America Pharmaceutical, INC. | $69.15 | 2024-2025 | Rexulti |
| Pacira Pharmaceuticals Incorporated | $65.20 | 2023-2024 | Iovera, Zilretta |
| Seqirus USA INC | $56.12 | 2022-2023 | Flucelvax Quadrivalent, Fluad Quadrivalent |
| Sunovion Pharmaceuticals INC. | $55.14 | 2021 | |
| Scilex Pharmaceuticals INC. | $52.52 | 2023 | Ztlido |
| Verity Pharmaceuticals INC. | $50.92 | 2024 | Tlando |
| Aimmune Therapeutics, INC. | $50.76 | 2024-2025 | Zenpep |
| Boston Scientific Corporation | $42.10 | 2025 | General - Pain Management |
| Idorsia Pharmaceuticals US INC | $40.54 | 2023 | Quviviq |
| Teva Pharmaceuticals USA, INC. | $37.63 | 2021 | |
| Tandem Diabetes Care, INC. | $36.25 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Agios Pharmaceuticals, INC. | $34.39 | 2025 | Pyrukynd |
| Fresenius Kabi USA, LLC | $31.56 | 2025 | |
| Upsher-Smith Laboratories LLC | $26.89 | 2021 | |
| Axsome Therapeutics, INC. | $26.87 | 2025 | Auvelity |
| Sanofi-Aventis U.S. LLC | $25.81 | 2021-2023 | |
| Radius Health, INC. | $19.82 | 2024 | Tymlos |
| Braintree Laboratories, INC. | $18.59 | 2025 | Suflave |
| Myovant Sciences INC. | $18.56 | 2022 | |
| Phadia US INC. | $16.95 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $16.64 | 2023 | Uptravi, Opsumit |
| Ironshore Pharmaceuticals INC. | $16.44 | 2021 | |
| Arbor Pharmaceuticals, INC. | $14.93 | 2021 | |
| Novavax INC | $14.89 | 2023 | Novavax Covid-19 Vaccine, Adjuvanted |
| Bausch Health US, LLC | $14.19 | 2023 | Aplenzin |
| Relievant Medsystems, INC. | $9.39 | 2023 | Intracept |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Schiff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.